Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE.
Saved in:
| Title: | Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE. |
|---|---|
| Authors: | Wei N; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany., Mathy RM; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany., Chang DH; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Institute of Radiology and Nuclear Medicine, Cantonal Hospital Lucerne, Spitalstrasse, Lucerne, CH-6000, Switzerland., Mayer P; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany., Liermann J; Liver Cancer Center Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Springfeld C; Liver Cancer Center Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany., Dill MT; Liver Cancer Center Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany.; Department of Gastroenterology, Hepatology, Infectious Diseases and Intoxication, University Hospital of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; German Cancer Research Center (DKFZ) Heidelberg, Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany., Longerich T; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany.; Institute of Pathology, University Hospital of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Lurje G; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany., Kauczor HU; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany., Wielpütz MO; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany. mark.wielpuetz@uni-greifswald.de.; Department of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse 1, 17475, Greifswald, Germany. mark.wielpuetz@uni-greifswald.de.; Clinic for Nuclear Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse 1, 17475, Greifswald, Germany. mark.wielpuetz@uni-greifswald.de., Öcal O; Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital of Heidelberg, Heidelberg, Germany. |
| Source: | Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2025 Aug 19; Vol. 25 (1), pp. 104. Date of Electronic Publication: 2025 Aug 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
